Collagen Encyclopedia — Scientific Background

What Is Collagen?

Collagen is the most abundant protein in the human body, accounting for approximately 30% of total protein mass. It is the primary building block of skin, muscles, bones, tendons, ligaments, and other connective tissues, and is also found in organs, blood vessels, and the intestinal lining. Structurally, collagens are characterized by a unique triple-helical conformation composed of three polypeptide chains rich in glycine, proline, and hydroxyproline.

Collagen Types and Sources

Collagen exists in multiple types, each with distinct structural and functional roles:

• Type I — Makes up approximately 90% of the body’s collagen; provides structure to skin, bones, tendons, and ligaments

• Type II — Found in elastic cartilage; provides joint support

• Type III — Found in muscles, arteries, and organs; preserves elasticity in the dermis

Commercial hydrolyzed collagen is primarily sourced from:

• Bovine — Hide, skin, bones, and connective tissue; high content of Type I and Type III collagen

• Porcine — Skin and bones; high content of Type I and Type III collagen

• Marine — Fish skin, scales, and bones; predominantly Type I collagen

Absorption Mechanism — Peptide Transport Pathway

Following oral ingestion, hydrolyzed collagen undergoes enzymatic digestion, producing low-molecular-weight peptides that are transported across the intestinal barrier via the proton-coupled oligopeptide transporter-1 (PepT1). Di- and tripeptides, particularly proline-hydroxyproline (Pro-Hyp), are absorbed intact and accumulate in connective tissues.

In humans, a single 10 g dose of collagen hydrolysate increases plasma free hydroxyproline by seven- to ten-fold and introduces measurable Pro-Hyp, hydroxyproline-glycine (Hyp-Gly), and related peptides. Pro-Hyp rapidly becomes the dominant circulating species despite its low content in the supplement, suggesting preferential liberation and high stability that enhance delivery to collagen-rich tissues such as skin, cartilage, and bone.

Mechanisms of Action

Fibroblast Activation and Matrix Regeneration

Once absorbed, collagen di- and tripeptides reach the dermis and cartilage to stimulate fibroblast proliferation, increase type I and type III procollagen messenger RNA (mRNA) levels, and enhance extracellular matrix synthesis. Collagen peptides modulate TGF-β/SMAD and MAPK signaling pathways, enhance COL1A1/COL3A1 transcription, and reduce matrix metalloproteinase (MMP) activity, promoting tissue remodeling and regeneration.

Skin Health — Hydration and Elasticity

Collagen peptides improve skin hydration by stimulating fibroblasts to produce collagen, elastin, and hyaluronic acid—components essential for skin moisture retention and elasticity. Clinical studies demonstrate that oral collagen supplementation significantly increases dermal collagen density, skin hydration, and skin elasticity compared with placebo.

Joint Health — Cartilage Support

Collagen peptides support joint health through immune-mediated oral tolerance mechanisms and by providing building blocks for cartilage matrix synthesis. They may also reduce inflammation and oxidative stress that erode connective tissues by suppressing TNF-α and IL-6 release. A randomized controlled trial in osteoarthritis patients demonstrated that 10 g/day of Type I and III hydrolyzed collagen peptides significantly improved WOMAC scores and ankle-hindfoot function over 8 weeks.

Hair, Nail, and Bone Support

Type I and Type III collagen peptides promote healthy hair and nail growth, support joint health and function, and contribute to bone strength.

The Bioavailability Challenge

Native collagen is a large protein with a molecular weight of approximately 300 kDa and poor water solubility. Its triple-helical structure resists enzymatic digestion and is not efficiently absorbed through the intestinal epithelium. Hydrolyzed collagen addresses these limitations by cleaving the protein into low-molecular-weight peptides (1–5 kDa) that are water-soluble, non-gelling, and readily absorbed.

However, even hydrolyzed collagen faces absorption challenges. Processing conditions, molecular weight, raw-material origin, genetic variability, gut microbiome composition, and mucosal health influence digestion kinetics and transporter activity. Age-associated reductions in enzyme secretion and intestinal surface area can further reduce collagen uptake.

Liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects collagen peptides during digestive transit, prevents enzymatic degradation, and enhances cellular uptake through lipid-mediated pathways.

Liposomal collagen

Liposomal encapsulation of hydrolyzed collagen provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the collagen peptide complex, forming a shield that protects it from enzymatic degradation in the gastrointestinal tract. This delivery system:

• Protects collagen peptides from gastric and intestinal enzymatic degradation

• Enhances intestinal absorption through lipid-mediated pathways

• Complements the PepT1 peptide transport pathway

• Improves delivery of bioactive peptides to dermal fibroblasts and chondrocytes

A randomized, double-blind, placebo-controlled trial in 75 healthy adults demonstrated that liposomal delivery significantly enhances the functional effects of collagen tripeptides on dermal structure and biomechanical performance, particularly dermal collagen density and skin elasticity, as well as optical skin properties including luminance and tone evenness. These findings support the application of liposomal collagen formulations as an effective oral nutricosmetic strategy for improving visible signs of skin aging.

Clinical Evidence

Skin Health

In a randomized, double-blind, placebo-controlled trial, 75 healthy adults aged 25–65 years were assigned to receive placebo, a non-liposomal collagen tripeptide formulation, or a liposomal collagen tripeptide formulation (50 mL/day) for 8 weeks. Objective assessments of dermal collagen density, skin hydration, elasticity, wrinkle area, skin luminance, and tone evenness were performed at baseline and Weeks 2, 4, and 8. Both collagen tripeptide groups showed significant improvements in dermal collagen density, hydration, and elasticity compared with placebo (p < 0.05). The liposomal formulation demonstrated an earlier onset and greater magnitude of improvement across multiple parameters, with a statistically significant advantage in skin elasticity at Week 8 compared with the non-liposomal formulation (p < 0.05). Notably, only the liposomal collagen tripeptide group exhibited a significant reduction in wrinkle area at Week 8 relative to placebo (p < 0.05).

Joint Health

A randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of oral supplementation with Type I and Type III hydrolyzed collagen peptides in 160 adult patients with osteoarthritis. Participants received either 10 g/day of collagen peptides or placebo for 8 weeks. The collagen peptide group showed a significant decrease in WOMAC scores (mean ± SD 50.5 ± 17.0 to 33.8 ± 16.5) and a significant increase in AOFAS-AHFS scores (64.2 ± 13.1 to 80.8 ± 9.9) at weeks 1, 4, and 8 compared to baseline. WOMAC scores were significantly lower and AOFAS-AHFS scores were significantly higher in the collagen peptide group compared to placebo at weeks 4 and 8 (all p < 0.001). The study concluded that hydrolyzed collagen peptides appear to be a safe and effective option for the symptomatic management of osteoarthritis, significantly improving joint pain, stiffness, and physical function in multiple joints.

Safety and Regulatory

Hydrolyzed collagen is generally well tolerated. Clinical trials using collagen peptides at doses of 10 g/day for 8 weeks have reported no serious adverse events. Collagen peptides are widely commercialized as dietary supplement ingredients and food ingredients. In the United States, hydrolyzed collagen has an established history of safe use as a dietary supplement. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. USP has an active collagen standard development program to establish monographs for hydrolyzed collagen and native collagen. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

79$/KG